Search - tctmd.com

Displaying 181 - 200 of 238

Sort: Relevancy | Date

Presentation OPCI 2019

Optimal Duration of Antiplatelet Therapy – Does IV Imaging Make A Difference?

Presenter: Roxana Mehran

March 09, 2019

Presentation OPCI 2019

Show Me the Data: Evidence That Physiologic Lesion Assessment Improves Patient Outcomes

Presenter: Habib Samady

March 09, 2019

Presentation OPCI 2019

High Definition IVUS as a tool to optimize PCI

Presenter: Akiko Maehara

March 09, 2019

Presentation OPCI 2019

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

Presenter: William F. Fearon

March 09, 2019

News Daily News

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Michael O'Riordan

March 01, 2019

News Daily News

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Michael O'Riordan

January 11, 2019

News Daily News

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

Michael O'Riordan

January 03, 2019

News Daily News

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

Todd Neale

November 05, 2018

News Daily News

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

Yael L. Maxwell

October 23, 2018

News Conference News TCT 2018

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

Yael L. Maxwell

September 24, 2018

Podcast TCTMD Talking Points

FAME 2: 3-Year Clinical and Cost-Effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

September 05, 2018

News Conference News ESC 2018

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

Michael O'Riordan

August 29, 2018

News Conference News ESC 2018

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

Todd Neale

August 26, 2018

News Daily News

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Michael O'Riordan

August 23, 2018

News Daily News

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

Michael O'Riordan

August 21, 2018

News Conference News ESC 2018

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Shelley Wood

August 20, 2018

News Daily News

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

L.A. McKeown

August 09, 2018

News Daily News

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Michael O'Riordan

July 10, 2018

News Daily News

Once Again, ISCHEMIA Trial Feels the Squeeze

Michael O'Riordan

June 29, 2018

News Daily News

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Michael O'Riordan

June 07, 2018

Advertisement

Optimal Duration of Antiplatelet Therapy – Does IV Imaging Make A Difference?

Show Me the Data: Evidence That Physiologic Lesion Assessment Improves Patient Outcomes

High Definition IVUS as a tool to optimize PCI

Basics of Coronary Physiology: FFR-Guided PCI in Stable CAD

ISCHEMIA Patients: High Rates of Severe-to-Moderate Ischemia, Multivessel CAD

Irrational Exuberance or Evidence-Based Medicine: What Role for CT Angiography in Stable Chest Pain?

Nicardipine Alleviates ‘Slow Flow’ in Chest-Pain Patients Without Obstructive CAD

High-Sensitivity Troponin Assays May Help Cut Down on Unnecessary Stress Tests, Study Suggests

Coronary CTA for Suspected CAD Shows Advantages in Predicting Hard Outcomes Over 10 Years

Next Steps With NIRS: Lipid-Rich Plaque Study Shows Promise Identifying High-Risk Patients, Plaques

FAME 2: 3-Year Clinical and Cost-Effectiveness Outcomes of FFR-Guided PCI in Patients With Coronary Artery Disease

New ESC/EACTS Revascularization Guidelines Make Room for Radial First, STICH, and DES for All

FUTURE Results Confirm More Deaths With FFR-Guided Treatment Choice

‘Immediate’ Return to Normal Flow Post-PCI in ORBITA-Like Patients

Cancelled Cath Lab Activations and Timely Reperfusion: A ‘Balancing Act’

ESC 2018: Trimming DAPT, New NOAC Niches, Aspirin Scrutiny for Primary Prevention, and More

Coronary Microvascular Dysfunction May Be a Marker of CV Risk in Obese Patients

ORBITA Redux: Lancet Correspondence Takes Talk of the Sham-Controlled PCI Trial to Further Heights

Once Again, ISCHEMIA Trial Feels the Squeeze

Liability Reform Changes How Docs Manage Suspected Coronary Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content